Case records of the Massachusetts General Hospital

New England Journal of Medicine

Volumn 340, Issue 4, 1999, Pages 300-307

  Scully, Robert E ^a   Mark, Eugene J ^a   McNeely, William F ^a   Ebeling, Sally H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MONONEUROPATHY MULTIPLEX; NEUROPATHY; PATHOLOGY; PRIORITY JOURNAL; SPINAL CORD DISEASE; VASCULITIS;

ADRENAL CORTEX HORMONES; ADULT; CRYOGLOBULINEMIA; CRYOGLOBULINS; DIAGNOSIS, DIFFERENTIAL; ELECTROMYOGRAPHY; FEMALE; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEURAL CONDUCTION; PARESTHESIA; VASCULITIS; VISION DISORDERS;

EID: 0033611477     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199901283400409     Document Type: Article

References (52)

1. Menkes DL, Hood DC. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 1996;119:676-80.
2. Dyck PJ, Dyck PJ, Grant IA, Fealey RD. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology 1996;47: 10-7.
3. Beck RW, Smith CH. Neuro-ophthalmology: a problem-oriented approach. Boston: Little, Brown, 1988.
4. Menkes DL, Hood DC, Ballesteros RA, Williams DA. Root stimulation improves the detection of acquired demyelinating polyneuropathies. Muscle Nerve 1998;21:298-308.
5. Amrit AN, Anderson MS. Serum creatinc phosphokinase in amyotrophic lateral sclerosis: correlation with sex, duration, and skeletal muscle biopsy. Neurology 1974;24:834-7.
6. Sehgal M, Swanson JW, DeRemec RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc 1995;70:337-41.
7. Nishino H, Rubino FA, Parisi JE. The spectrum of neurologic involvement in Wegener's granulomatosis. Neurology 1993;43:1334-7.
8. Zuniga G, Ropper AH, Frank J. Sarcoid peripheral neuropathy. Neurology 1991;41:1558-61.
9. Lightfoot RW Jr, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990;33:1088-93.
10. Schumacher HR, Klippe JH, Koopman WJ, eds. Primer on the rheumatic diseases. 10th ed. Atlanta: Arthritis Foundation, 1993.
11. Barland P, Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med 1996;100:16S-23S.
12. Pozzetto B, Bourlet T, Grattard F, Bonnevial L. Structure, genomic organization, replication and variability of hepatitis C virus. Nephrol Dial Transplant 1996;11:Suppl 4:2-5.
13. Agnello V, Romain PL. Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am 1996;22:1-21.
14. Gordon SC. Extrahepatic manifestations of hepatitis C. Dig Dis 1996; 14:157-68.
15. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
16. Botte C, Janot C. Epidemiology of HCV infection in the general population and in blood transfusion. Nephrol Dial Transplant 1996;11:Suppl 4:19-21.
17. Fornasieri A, Armelloni S, Bernasconis P, et al. High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996;27:476-83.
18. Van Thiel DH, Fagiuoli S, Caraccni P, et al. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol 1995;22:464-7.
19. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57:775-88.
20. Khella SL, Frost S, Hermann GA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy: treatment with interferon alfa: case report and literature review. Neurology 1995;45:407-11.
21. Apartis E, Leger JM, Musset L, et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996;60:661-6.
22. Karlsberg PL, Lee WM, Casey DL, Cockerell CJ, Cruz PD Jr. Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia. Arch Dermatol 1995;131: 1119-23.
23. Cosserat J, Cacoub P, Bletry O. Immunological disorders in C virus chronic hepatitis. Nephrol Dial Transplant 1996;11:Suppl 4:31-5.
24. Merlini G, Zorzoli I, Anesi E, Perfetti V, Marinone G. Immunochemical characterization of the cryoglobulins: pathophysiologic implications. Clin Exp Rheumatol 1995;13:Suppl 13:S71-S73.
25. Campioli G, Ghini M, Mascia MT, et al. Characterization of cryoglobulins: some remarks on methodology. Clin Exp Rheumatol 1995;13:Suppl 13:S75-S78.
26. Shihabi ZK. Analysis and general classification of serum cryoglobulins by capillary zone electrophoresis. Electrophoresis 1996;17:1607-12.
27. de Maddalena C, Zehender G, Bianchi Bosisio A, et al. HCV-RNA detection using different PCR methods in sera, cryoglobulins and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13:Suppl 13:S119-S122.
28. Ferri C, Zignego AL, Bombardieri S, et al. Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas. Clin Exp Rheumatol 1995;13:Suppl 13:S135-S140.
29. Wei G, Yano S, Kuroiwa T, Hiromura K, Maezawa A. Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease. Clin Exp Immunol 1997;107:83-8.
30. Ueda K, Nakagawa T, Shimizu A, Nakajima H, Fukuda A, Ohsawa N. Rheumatoid factor in the serum of hepatitis C virus-infected patients: an increase in the titre during cold storage. Ann Clin Biochem 1996;33:438-42.
31. Wooten MD, Jasin HE. Mixed cryoglobulinemia and vasculitis: a novel pathogenic mechanism. J Rheumatol 1996;23:1278-81.
32. Marrogi AJ, Cheles MK, Gerber MA. Chronic hepatitis C: analysis of host immune response by immunohistochemistry. Arch Pathol Lab Med 1995;119:232-7.
33. Antinori S, Galimberti L, Rusconi S, Zehender G, Esposito R, Galli M. Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. Clin Exp Rheumatol 1995;13:Suppl 13:S157-S159.
34. Nemni R, Corbo M, Fazio R, Quattrini A, Comi G, Canal N. Cryoglobulinaemic neuropathy: a clinical, morphological and immunocytochemical study of 8 cases. Brain 1988;111:541-52.
35. NIH Consensus Development Conference on management of hepatitis C: program and abstracts. Bethesda, Md.: National Institutes of Health, 1997:1-41.
36. Agnello V. Mixed cryoglobulinemia and hepatitis C virus. Hosp Pract (Off Ed) 1995;30:35-42.
37. Ferri C, La Civita L, Monti M, et al. Chronic hepatitis C and B-cell non-Hodgkin's lymphoma. QJM 1996;89:117-22.
38. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-53.
39. Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-8.
40. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
41. Izumi T, Sasaki R, Tsunoda S, Akutsu M, Okamoto H, Miura Y. B cell malignancy and hepatitis C virus infection. Leukemia 1997;11:Suppl 3:516-8.
42. Silvestri F, Bariliari G, Fanin R, et al. Hepatitis C virus infection among cryoglobulincmic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997;82:314-7.
43. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoprolifcration. Blood 1996;88:4638-45.
44. Ferri C, Lo Jacono F, Monti M, et al. Lymphotropic virus infection of peripheral blood mononuclear cells in B-cell non Hodgkin's lymphoma. Acta Haematol 1997;98:89-94.
45. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:1887-92.
46. Mazzaro C, Franzin F, Tulissi P, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996;77:2604-13.
47. Ellis M, Rathaus M, Amiel A, Manor Y, Klein A, Lishner M. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia. Eur J Clin Invest 1995;25:833-7.
48. Monteverde A, Sabattini E, Poggi S, et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 1995;20:11924.
49. Ascoli V, Lo Coco F, Artini M, Levrero M, Fruscalzo A, Mecucci C. Primary effusion Burkitt's lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis. Hum Pathol 1997;28:101-4.
50. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;70:4438-43.
51. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995;69:3893-6.
52. De Vita S, Gasparotto D, Pivetta B, et al. Rarity of microsatellite genomic instability in B-cell non-Hodgkin's lymphomas in hepatitis C virus-infected patients. Br J Haematol 1997;97:463-5.